Domov › Rak mehurja › Michigan

Klinične študije za Rak mehurja v Michigan

25 študij za Rak mehurja išče udeležence na lokacijah v Michigan.

Mesta v Michigan

Uradno besedilo študije (angleško)

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
in še 68

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health Medical Center - Brighton, Brighton
Trinity Health Medical Center - Canton, Canton
in še 8

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06770582

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Profound Research -OMG - TriAtria Cancer Center, Farmington Hills

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06760819

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
Trinity Health Medical Center - Brighton, Brighton
in še 32

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Munson Medical Center ( Site 0812), Traverse City

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Karmanos Cancer Institute, Detroit

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07218380

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

START Midwest, Grand Rapids

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05267626

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

START Midwest, Grand Rapids

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Cancer & Hematology Centers of Western Michigan, Grand Rapids

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Regents of the University of Michigan, Ann Arbor

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07144319

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Comprehensive Urology, Royal Oak
Michigan Institute of Urology (Solaris), Troy

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

Henry Ford Cancer Institute-Downriver, Brownstown
Henry Ford Health Center - Brownstown, Brownstown
Henry Ford Health Center - Chesterfield, Chesterfield
in še 13

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 45–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06995898

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Barbara Ann Karmanos Cancer Institute, Detroit

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT05614739

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Research Site, Grand Rapids

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT07129993

Measuring Surgical Recovery After Radical Cystectomy

Spectrum Health Medical Group, Grand Rapids

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

University of Michigan Rogel Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
University of Michigan - Brighton Center for Specialty Care, Brighton
in še 22

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07097142

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Henry Ford Health System, Detroit
Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT04752722

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Karmanos Cancer Institute, Detroit

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT07106762

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

The Cancer & Hematology Centers, Big Rapids
Karmanos Cancer Institute, Detroit
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
in še 7

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 22. jul. 2026 · NCT04879329

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

START Midwest, Grand Rapids

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT07030257

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Ann Arbor
Massive Bio SYNERGY-AI site, Lansing

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

Karmanos Cancer Institute, Detroit

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 9. jul. 2025 · NCT05086692

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.